SOUNDTRACK: THE FRONT BOTTOMS-Tiny Desk Concert #297 (August 19, 2013).
I really enjoyed The Front Bottoms’ “Au Revoir” and was pretty excited to see they had a Tiny Desk Concert. After watching this, I’m very curious to see what they do in a full band setting because their sound works very well in this stripped down fashion–with acoustic guitars, penny whistle and muted trumpet (!).
Lead singer, Brian Sella, reminds me a lot of Mike Doughty in his speaky/singing way (especially on “Swear To God The Devil Made Me Do It”–although less speaky than Doughty or Cake–there’s just something about his delivery that puts me in mind of them.
He’s also always got a smirk on his face, which makes me like them more.
I’m torn between wondering if they’re a novelty band that I wouldn’t listen to more than a few times or a cool alternative band whose idiosyncrasies only get better with each listen. I love the way “Twin Size Mattress” has little elements (like the tambourine moment–and the “no fucking way moment) which elevate it above some of the seemingly sillier songs. Not to mention the lyrics are really good in the song. Indeed, even though the lyrics are funny, they are often very clever, too.
I really enjoyed all four songs in this set and I have listened to it many times now. “Au Revoir (Adios)” sounds great. All four songs comes from their new album Talon of the Hawk. And the more I listen the more I’m convincing myself to jut get the damned album.
[READ: September 6, 2013] “Gaboxadol”
This essay was actually hard for me to read. That’s because the first half was all scientific chemistry talk and I really got lost–I don’t really know what GABA receptors are or do and I didn’t even really understand what he was talking about what Stepan Krasheninnikov did in 1755. And I worried that I wasn’t going to enjoy this at all.
But soon Morris brought it back to an area that dummies like me can enjoy He talks about the history of Gaboxadol a drug created by Dutch chemist Povl Krogsgaard-Larsen in 1977. The first time Povl took it (self-experiment was very common until recently) he said it made him feel like he had just had three beers–a very comfortable feeling.
But Gaboxadol never found its niche. Povl knew it had relaxing qualities but he couldn’t specifically diagnose who would best benefit from it. It was tried on the mentally ill. The desired effects did not really arrive–but the side effects made people feel sleepy. Then it was tried as an analgesic for cancer patients. It relieved some pain but it made everyone sleepy (you see where this is gong, right?). It was then tested on patients with anxiety disorder, but the side effects were more powerful that the anti-anxiety effects.
So then the drug was just shelved (were people just less experimental back then?) It wasn’t until 1996 that Marike Lancel a somnologist in Munich read the research and decided to try it as a sleeping aid. She realized that Gaboxadol assisted sleep and also had none of the side effects that Ambien had (apparently terrible insomnia once you stop taking it–so I’ll not be taking that, thank you very much). Merck bought the rights to Gaboxadol for $270 million. (more…)


